Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 05. März 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2962  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 59235  
   
Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer.
J Control Release
Sandhya T, Kumari S, Meghapriya A, Manam VKC, Nagaraju GP, Srilatha M.
PMID: 41780688 [PubMed - as supplied by publisher]


Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET.
ESMO Open
Hadoux J, Hernando J, Wong KH, Do Cao C, Lasolle H, Buffet C, Benisvy D, Illouz F, Schneegans O, Varnier R, Drui D, Zanetta S, Hescot S, Muller M, Nascimento C, Roudaut N, Khanal M, Zheng S, Li X, Singh R, Tian W, Afonso AS, Houot B, Borget I, Segall G.
PMID: 41780123 [PubMed - as supplied by publisher]


Authors' Response: Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study.
J Gastrointest Cancer
Maan MHA, Al-Khazraji A.
PMID: 41779300 [PubMed - in process]


A Sequential Proteomic Relay Defines a Decade-long Pre-diagnostic Window for Pancreatic Cancer.
Cancer Diagn Progn
Lehrer S, Rheinstein PH.
PMID: 41778239 [PubMed]


Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.
Lancet Reg Health Eur
Peeters SLJ, Heersche N, Böhm D, Böhringer S, Guiljam R, Hulshof EC, de Man FM, de With M, Joosse M, Oomens G, Wu QY, Osman A, Bins S, van Hellemond IEG, Haberkorn BCM, Verschoor AJ, Wumkes ML, van Schaik RHN, Thijs AM, Gelderblom H, Guchelaar HJ, Mathijssen RHJ, Deenen MJ.
PMID: 41777427 [PubMed]


Trends in cancer burden in Pakistan: a 30-year analysis from the Global Burden of Disease Study (1990-2019).
Ecancermedicalscience
Bhojwani KM, Raheem A, Khan UT, Javid F, Tanweer D, Rehmani N, Khan NU, Khan SR.
PMID: 41777412 [PubMed]


Clinical Characteristics and Prognostic Factors of Renal Sarcoma: A Japanese National Cancer Registry Study.
Cancer Invest
Kondo H, Ogura K, Morizane C, Satake T, Iwata S, Toda Y, Muramatsu S, Takemori T, Kobayashi E, Higashi T, Kawai A.
PMID: 41777120 [PubMed - as supplied by publisher]


An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study.
Mol Cancer
Miyazaki K, Montcusí B, Morine Y, Okuno K, Pascual M, Tokunaga T, Noma T, Kinugasa Y, Shimada M, Cai G, Pera M, Goel A.
PMID: 41776599 [PubMed - as supplied by publisher]


The role of complete mesocolic excision with central vascular ligation in colon cancer surgery: A systematic review and meta-analysis of prospective trials.
Eur J Surg Oncol
Kitaguchi D, Forgione A, Innocenzi C, Yang Y, Espínola F, Giménez M, Oda T, Marescaux J.
PMID: 41774976 [PubMed - as supplied by publisher]


Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.
J Clin Oncol
Walter TP, Mazieres J, Otto J, Lena H, Lepage C, Smith D, Madelaine J, Gérinière L, Egenod T, El Hajbi F, Ferru A, Clément-Duchene C, Madroszyk A, Brotelle T, Bouhier-Leporrier K, Desrame J, Ghiringhelli F, Paleiron N, Khalil A, Milot L, Chevallier O, Couvelard A, Lantuejoul S, Langlais A, Morin F, Duruisseaux M, Michel P, Louvet C, Westeel V, Girard N, IFCT-FFCD-GERCOR GCO.
PMID: 41774886 [PubMed - as supplied by publisher]


Perioperative Immunotherapy for Pancreatic Cancer: A Systematic Review of Randomized Controlled Trials.
J Gastrointest Cancer
Saeed TS, Saeed MR, Qureshi MS, Habib N, Ashraf U, Mehtab S, Abdullah MF, Iqbal Chowdhury MF, Saeed A, Razzaq K, Maqbool MA.
PMID: 41772269 [PubMed - in process]


Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum.
Commun Med (Lond)
Peterka O, Jirásko R, Dole, Dosoudilová M, Bártl J, Idkowiak J, Slaví, Pe, Vo, Mohelníková-Ducho, Kozubíková I, Love, Urban O, Trna J, Karásek P, Melichar B, Hol.
PMID: 41772143 [PubMed]


Role of Devine gastric partitioning in locally advanced gastric cancer: palliation and bridge to definitive care-protocol for a systematic review.
BMJ Open
Gomes A, Reis MI, Costa B, Nunes V.
PMID: 41771589 [PubMed - in process]


The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) 10 years of Past Accomplishments and Looking Forward to the Next 5 Years of the Chronic Pancreatitis Clinical Research Consortium (CPCRC).
Pancreas
Forsmark CE, Pandol S.
PMID: 41771024 [PubMed - as supplied by publisher]


Lorazepam and Survival in Asian Patients with Pancreatic Cancer: A Retrospective Cohort Study.
J Gastrointest Cancer
Lee TS, Choi JH, Cho IR, Park JW, Lee SH, Ryu JK, Paik WH.
PMID: 41770476 [PubMed - in process]


Validation of the predictive value of combined prealbumin and lymphocyte score for prognosis of stage II/III gastric cancer following curative resection.
Front Oncol
Peng W, Tan Y, Cheng J, Wu Z, Ou S, Luo J, Xiao H.
PMID: 41768246 [PubMed]


Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis.
Front Med (Lausanne)
Cretu OI, Lungulescu CV, Gentiluomo M, Turcu-Stiolica A, Pani, Patrascu S, Ungureanu BS.
PMID: 41767502 [PubMed]


Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis.
Front Immunol
Zheng Q, Jin S, Xie X, Guo Q, Chen C, Jiang W.
PMID: 41766905 [PubMed - in process]


Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer.
J Immunother Precis Oncol
Khawaja MR, Jameson G, Cridebring D, Shannon P, Han H, Moore J, Von Hoff D, Posner RG, Hlavacek WS, Kolch W, Kholodenko BN, Rukhlenko OS, Roe DJ, Wertheim BC, Borazanci E.
PMID: 41766762 [PubMed]


Differential Efficacy of Immunotherapy for Hepatocellular Carcinoma by Aetiology: A Systematic Review and Meta-Analysis.
Clin Oncol (R Coll Radiol)
Li Y, Tan X, Fang S, So C.
PMID: 41764966 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 59235    Seite 1 von 2962  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1